scholarly article | Q13442814 |
P5530 | Altmetric DOI | 10.1016/J.JCONREL.2018.05.005 |
P6179 | Dimensions Publication ID | 1103972056 |
P356 | DOI | 10.1016/J.JCONREL.2018.05.005 |
P953 | full work available at URL | http://eprints.whiterose.ac.uk/132017/ |
P932 | PMC publication ID | 6026028 |
P698 | PubMed publication ID | 29753957 |
P1154 | Scopus EID | 2-s2.0-85047251823 |
P50 | author | Daniel Coluccia | Q56450174 |
Heiko Wurdak | Q89782444 | ||
Kullervo Hynynen | Q31088142 | ||
P2093 | author name string | James T Rutka | |
Brian Golbourn | |||
Christian Smith | |||
Nesrin Sabha | |||
Meaghan O'Reilly | |||
Amanda Luck | |||
Saira Alli | |||
Andrew Bondoc | |||
Carlyn A Figueiredo | |||
Colin Maslink | |||
Megan Yijun Wu | |||
P2860 | cites work | K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas | Q24615283 |
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas | Q24629777 | ||
Chronic, intermittent convection-enhanced delivery devices | Q26776237 | ||
DIPG in Children - What Can We Learn from the Past? | Q26777843 | ||
Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study | Q27334453 | ||
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma | Q28237518 | ||
In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma | Q28487205 | ||
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma | Q28833173 | ||
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma | Q29616862 | ||
Characterization of Different Microbubbles in Assisting Focused Ultrasound-Induced Blood-Brain Barrier Opening. | Q30358276 | ||
Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound: Preclinical Testing on a Trans-Human Skull Porcine Model. | Q30367034 | ||
Intracranial applications of magnetic resonance-guided focused ultrasound. | Q30384529 | ||
Focused ultrasound-mediated drug delivery through the blood-brain barrier | Q30394357 | ||
Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors | Q30407973 | ||
Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology | Q30434475 | ||
Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? | Q47580461 | ||
Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume | Q48346915 | ||
An epigenetic therapy for diffuse intrinsic pontine gliomas. | Q48424265 | ||
Intracerebral chemotherapy: chronic microinfusion of cisplatin | Q48968255 | ||
Mechanism of Low-Frequency Ultrasound in Opening Blood–Tumor Barrier by Tight Junction | Q50441989 | ||
Short and long-term motor skill learning in an accelerated rotarod training paradigm. | Q52090583 | ||
In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. | Q54172518 | ||
Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema. | Q55488962 | ||
Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes | Q69485193 | ||
Focused ultrasound delivers targeted immune cells to metastatic brain tumors | Q30441716 | ||
Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma | Q30448863 | ||
Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques | Q30452238 | ||
Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller | Q30455962 | ||
Ultrasound insertion loss of rat parietal bone appears to be proportional to animal mass at submegahertz frequencies | Q30462013 | ||
A PVDF receiver for ultrasound monitoring of transcranial focused ultrasound therapy | Q30472865 | ||
Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. | Q30474719 | ||
Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium | Q30488665 | ||
Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q30500905 | ||
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications | Q30837732 | ||
Advances toward an understanding of brainstem gliomas | Q31033870 | ||
Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations | Q33354476 | ||
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma | Q33751426 | ||
Chemotherapy for brain stem gliomas | Q33768045 | ||
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. | Q33895267 | ||
Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits | Q33954300 | ||
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. | Q33958482 | ||
A non-invasive method for focusing ultrasound through the human skull | Q33959339 | ||
Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier | Q33999429 | ||
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma | Q34810691 | ||
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study | Q37152041 | ||
Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation. | Q37577170 | ||
Diffuse intrinsic pontine gliomas: treatments and controversies | Q38216988 | ||
Modeling localized delivery of Doxorubicin to the brain following focused ultrasound enhanced blood-brain barrier permeability | Q39127658 | ||
Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption | Q39290193 | ||
Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose | Q43693994 | ||
Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children | Q44156403 | ||
MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits | Q46802417 | ||
P4510 | describes a project that uses | focused ultrasound | Q50333304 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
blood–brain barrier | Q221694 | ||
P304 | page(s) | 29-41 | |
P577 | publication date | 2018-05-16 | |
P1433 | published in | Journal of Controlled Release | Q6295046 |
P1476 | title | Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. | |
P478 | volume | 281 |
Q101237517 | Applications of focused ultrasound in the brain: from thermoablation to drug delivery |
Q90317315 | First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound |
Q89967058 | Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma |
Q57167169 | Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases |
Q55251609 | Malignant Brain Tumours in Children : Present and Future Perspectives. |
Q94602503 | Overcoming the blood brain barrier to target diffuse intrinsic pontine glioma: What's new? |
Q64244053 | Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges |
Search more.